Details

Autor(en) / Beteiligte

• Punneshetty, S
• Thomas, V
• Sebastian, A
• Thomas, DS
• Thomas, A
• Chandy, RG
• Peedicayil, A

Titel

629 Audit of management of advanced ovarian cancers at a gynaecologic oncology department –as per ESGO 2020 updated guidelines

Ist Teil von

• International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A258-A259

Ort / Verlag

Oxford: BMJ Publishing Group Ltd

Erscheinungsjahr

2021

Beschreibungen/Notizen

• Introduction/Background*The aim of this audit is to assess the compliance of the Department of Gynaecological Oncology, in a tertiary care hospital, India in the management of advanced ovarian cancers, as per the updated European Society of Gynaecology Oncology(ESGO 2020) quality indicators for advanced ovarian cancer .MethodologyDesignA retrospective auditSettingDepartment of Gynaecologic Oncology, tertiary hospital in India, accredited by ESGO in 2019PatientsElectronic hospital records of 106 patients with advanced ovarian cancer, between Janary 1, 2019 – 31 December 2019 were identified, reviewed and analysed using SPSS Version 21.Result(s)*Ninety out of 106 patients, underwent cytoreductive surgeries by trained gynaecologic oncologists during this period. The first quality indicator target was not met as the complete resection and primary cytoreductive rates were 49% and 37% respectively. Other quality indicators with regard to case load, skills, training and surgeon’s experience were fulfilled. Majority (95%) of the patients were discussed in multi disciplinary board meet. Targets for quality indicators with regard to clinical trial recruitment, preoperative work up and discussion in multidisciplinary board, structured operative report, post-operative complication reporting were achieved. The department has supporting high dependency and intensive care units, but lacks an active perioperative management program. Compliance to pathology reporting was 64%. Overall, a total score of 25 was achieved.Conclusion*The revised quality indicators laid down by the ESGO helps in introspection and auditing of the department’s existing practices for advanced ovarian cancer. The audit revealed the need for judicious selection of patients for primary surgery, improving complete cytoreduction rates and a structured active perioperative management. Synoptic pathologic reporting improves completeness and accuracy.